Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Synaptopodin ELISA Kit (AC3415)
Cat.#: ASET-2004
Specifications
Description Human Synaptopodin ELISA Kit allows for the in vitro quantitative determination of human Synaptopodin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2524 Rat VEGFB ELISA Kit (AC3935) Quantitative inquiry ASET-1908 Mouse NCAM1 ELISA Kit (AC3319) Quantitative inquiry ASET-1465 Human Meteorin ELISA Kit (AC2876) Quantitative inquiry ASET-2432 Rat Caspase-12 ELISA Kit (AC3843) Quantitative inquiry ASET-1690 Human Aspartate beta Hydroxylase ELISA Kit (AC3101) Quantitative inquiry ASET-2482 Mouse ApoER2 ELISA Kit (AC3893) Quantitative inquiry ASET-1912 Rat NMDAR1 ELISA Kit (AC3323) Quantitative inquiry ASET-1529 Human IL-6 ELISA Kit (AC2940) Quantitative inquiry ASET-2153 Mouse GDF7 ELISA Kit (AC3564) Quantitative inquiry ASET-1931 Rat Aromatase ELISA Kit (AC3342) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket